New strategies for ms-based metabolomics
11 Feb 2016
New strategies for ms-based metabolomics
Polycystic kidney disease: Identifying a pathogenic pathway
The occurrence of septic shock: difficulty in predicting the outcomes
Mass spectrometry: a key metabolomics platform in metabolic diseases
Pharmametabolomics and the integration of metabolomics in drug discovery
How can metabolomics help in clinical diagnosis?
The blood-brain barrier in health and disease
Genome instability can be exploited for cancer therapy
What is the impact of TOR on nuclear dynamics?
What is the DNA-dependent protein kinase, DNA-PK?
DNA damage response is related to cellular homeostasis
Checkpoint machinery protects against cancer